Skip to main content
ASSURE TECH (HANGZHOU) CO., LTD. logo

ASSURE TECH (HANGZHOU) CO., LTD. — Investor Relations & Filings

Ticker · 688075 ISIN · CNE100004ZC0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2025-08-06 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688075

About ASSURE TECH (HANGZHOU) CO., LTD.

https://www.diareagent.com/

Assure Tech (Hangzhou) Co., Ltd. is a biotechnology enterprise specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and clinical testing instruments. The company focuses on rapid diagnostic tests and Point of Care Testing (POCT) solutions across various medical fields, including infectious diseases, drug of abuse screening, oncology, cardiac markers, and fertility. Utilizing advanced lateral flow immunoassay technology, Assure Tech provides diagnostic tools designed for accuracy and efficiency in clinical and laboratory settings. The company adheres to international quality standards, maintaining ISO 13485 certification and obtaining regulatory clearances such as FDA and CE marks for its product range. Through its integrated R&D and production infrastructure, Assure Tech supplies a diverse portfolio of diagnostic products to a global customer base.

Recent filings

Filing Released Lang Actions
安旭生物关于董事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election and nomination of the company's new board of directors, including detailed biographies of the candidates and compliance with relevant laws and regulations. It explicitly discusses the board of directors' re-election process, qualifications, and legal compliance. There is no financial data, earnings information, or report publication mentioned. The content fits the category of Board/Management Information, specifically about changes in the company's board of directors. The document length is 4324 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the appropriate classification is MANG (Board/Management Information).
2025-08-06 Chinese
安旭生物第二届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the 18th meeting of the second board of directors of Hangzhou Anxu Biotechnology Co., Ltd. It details the nomination of candidates for the third board of directors, amendments to the company charter, and other board decisions. It references that these matters will be submitted to the shareholders' meeting for approval. The content focuses on board and management changes and related governance matters. There is no financial data or report content, only meeting resolutions and nominations. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and it is not a full report or financial statement, so it is not an Annual Report or Interim Report. It is not a voting result announcement (DVA) because it is about board meeting resolutions, not shareholder vote results. Hence, the classification is MANG with high confidence.
2025-08-06 Chinese
募集资金管理制度（202508）
Governance Information Classification · 95% confidence The document is titled '募集资金管理制度' which translates to 'Fundraising Capital Management System' and is issued by 杭州安旭生物科技股份有限公司 (Hangzhou Anxu Biotechnology Co., Ltd.). It details the management, storage, usage, supervision, and regulatory compliance related to the company's raised funds from securities issuance. The content includes references to laws, regulatory requirements, and internal controls for managing raised capital, including the use of funds, investment restrictions, reporting, and oversight mechanisms. There is no indication that this is an announcement or a brief summary; rather, it is a detailed internal policy document. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a regulatory filing or announcement. It is a governance-related document focused on the rules and procedures for managing capital raised by the company. Therefore, the most appropriate classification is Governance Information (CGR).
2025-08-06 Chinese
安旭生物关于召开2025年第一次临时股东大会通知公告
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2025 first extraordinary general meeting (临时股东大会) of Hangzhou Anxu Biotechnology Co., Ltd. It includes information about the meeting date, voting methods, agenda items including board elections, and instructions for shareholders on how to participate and vote. The content is focused on the announcement and procedural details of a shareholders' meeting rather than the meeting materials or results themselves. It does not contain financial statements, audit opinions, or earnings data. The document is over 5,000 characters and is not a brief announcement of a report publication but a full notice of a shareholders meeting. Therefore, the most appropriate classification is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2025-08-06 Chinese
股东会议事规则（202508）
Governance Information Classification · 100% confidence The document is titled '股东会议事规则' which translates to 'Rules of Procedure for Shareholders' Meetings' for 杭州安旭生物科技股份有限公司. It details the procedures, legal basis, and operational rules for convening and conducting shareholders' meetings, including annual and extraordinary meetings, proposal submissions, voting procedures, and related governance matters. It does not contain financial statements, audit opinions, or earnings data. It is a governance-related document outlining internal rules and practices for shareholder meetings. Therefore, it fits best under Governance Information (CGR). The document length (7776 characters) and content confirm it is a full governance rules document, not a brief announcement or a report publication notice.
2025-08-06 Chinese
董事会审计委员会工作细则（202508）
Governance Information Classification · 95% confidence The document is titled '董事会审计委员会工作细则' which translates to 'Board Audit Committee Working Rules'. It details the structure, responsibilities, procedures, and governance of the company's audit committee. It does not contain financial statements, audit results, or financial performance data. Instead, it outlines governance and operational rules for the audit committee, which is a governance-related document. There is no indication that this is an audit report, annual report, or any financial report. It is a governance document related to board committee rules and procedures. Therefore, the most appropriate classification is Governance Information (CGR). The document length is about 4926 characters, which is sufficient for a detailed governance report, not a mere announcement or certification.
2025-08-06 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.